Impaired kidney transplant survival in patients with antibodies to hepatitis C virus

Nephrology Dialysis Transplantation

Volumn 14, Issue 10, 1999, Pages 2455-2460

  Gentil, Miguel A ^a   Rocha, José L ^a   Rodríguez Algarra, Gabriel ^a   Pereira, Porfirio ^a   López, Raquel ^a   Bernal, Gabriel ^a   Muñoz, José ^a   Naranjo, Macarena ^a   Mateos, Julián ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

Acute transplant rejection; Chronic liver disease; Chronic renal failure; Hepatitis C; Kidney transplantation; Survival

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; HEPATITIS C ANTIBODY; LYMPHOCYTE ANTIBODY; STEROID;

ADULT; ARTICLE; BLOOD TRANSFUSION; CADAVER KIDNEY; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CHRONIC KIDNEY DISEASE; CHRONIC LIVER DISEASE; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HEMODIALYSIS; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA; SURVIVAL RATE;

ADULT; ANTILYMPHOCYTE SERUM; AZATHIOPRINE; CYCLOSPORINE; DRUG THERAPY, COMBINATION; FEMALE; GRAFT SURVIVAL; HEPATITIS C ANTIBODIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; STEROIDS; SURVIVAL ANALYSIS;

EID: 0032849076     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/14.10.2455     Document Type: Article

References (23)

1. Pirson Y, Goffin E. Hepatitis C infection in renal transplant patients: new insights and unanswered questions. Nephrol Dial Transplant 1996; 11: 42-45
2. Ponz E, Campistol JM, Bruguera M et al. Hepatitis C virus infection among kidney transplant recipients. Kidney Int 1991; 40: 748-751
3. Ynares C, Johnson HK, Kerlin T, Crowe D, MacDonell R, Richie R. Impact of pretransplant hepatitis C antibody status upon long-term patient and renal allograft survival - a 5- and 10-year follow-up. Transplant Proc 1993; 25: 1466-1468
4. Roth D, Zucker K, Cirocco R et al. The impact of hepatitis C virus infection on renal allograft recipients. Kidney Int 1994; 45: 238-244
5. Orloff SL, Stempel CA, Wright TL et al. Long-term outcome in kidney transplant patients with hepatitis C (HCV) infection. Clin Transplant 1995; 9: 119-124
6. Haem J, Berthoux P, Cecillon S, Mosnier JF, Pozzetto B, Berthoux F. HCV liver disease in renal transplantation: a clinical and histological study. Nephrol Dial Transplant 1996; 4: 48-51
7. Lee SW, Kang SW, Choi KH et al. Clinical outcome of anti-HCV(+) renal allograft recipients. Transplant Proc 1996; 28: 1501-1502
8. Durlik M, Gaciong Z, Soluch L et al. Results of kidney transplantation in HBsAg and anti-HCV seropositive renal allograft recipients. Transplant Proc 1996; 28: 3459-3460
9. Hestin D, Guillemin F, Castin N, Le Faou A, Champigneulles J, Kessler M. Pre-transplant hepatitis C virus infection: a predictor of proteinuria after renal transplantation. Transplantation 1998; 65: 741-744
10. Rodrigues A, Morgado T, Henriques AC, Sarmento AM, Pereira M, Guimaraes S. Outcome of renal graft recipients with hepatitis C virus infection. Transplant Int 1996; 9 [Suppl 1]: S28-31
11. Fritsche C, Brandes JC, Delaney SR et al. Hepatitis C is a poor prognostic indicator in black kidney transplant recipients. Transplantation 1993; 55: 1283-1287
12. Ihara H, Ikoma F. Influence of anti-hepatitis C virus antibody on kidney transplant survival in a single Japanese center. Transplantation 1994; 57: 781
13. Stehman-Breen CO, Psaty BM, Emerson S et al. Association of hepatitis C virus infection with mortality and graft survival in kidney-pancreas transplant recipients. Transplantation 1997; 64: 281-286
14. Pereira BJ, Wright TL, Schmid CH, Levey AS. The impact of pre-transplantation hepatitis C infection on the outcome of renal transplantation. Transplantation 1995; 60: 799-805
15. Legendre C, Garrigue V, Le Bihan C et al. Harmful long-term impact of hepatitis C virus infection in kidney transplant recipients. Transplantation 1998; 65: 667-670
16. Bouthot BA, Murthy BV, Schmid CH, Levey AS, Pereira BJ. Long-term follow-up of hepatitis C virus infection among organ transplant recipients: implications for policies on organ procurement. Transplantation 1997; 63: 849-853
17. Cruzado, JM, Gil-Vernet S, Ercilla G et al. Hepatitis C virus-associated membrane-proliferative glomerulonephritis in renal allograft. J Am Soc Nephrol 1996; 7: 2469-2475
18. Hammoud H, Haem J, Laurent B et al. Glomerular disease during HCV infection in renal transplantation. Nephrol Dial Transplant 1996; 11 [Suppl 4]: 54-55
19. Morales JM, Pascual J, Campistol JM et al. Membranous glomerulonephritis associated with hepatitis C virus infection in renal transplant patients. Transplantation 1997; 63: 1634-1639
20. Cosio FG, Sedmak DD, Henry ML et al. The high prevalence of severe early posttransplant renal allograft pathology in hepatitis C positive recipients. Transplantation 1996; 62: 1054-1059
21. Gentil MA, Rocha JL, Pereira P, R Algarra G, Lopez R. Diabetes after kidney transplant in patients with antibodies to hepatitis C. Nephron 1999; 82: 85
22. Knobler H, Stagnaro Green A, Wallenstein S, Schwartz M, Roman SH. Higher incidence of diabetes in liver transplant recipients with hepatitis C. J Clin Gastroenterol 1998; 26: 30-33
23. Grimbert S, Valensi P, Levy-Marchal C et al. High prevalence of diabetes mellitus in patients with chronic hepatitis C. A case-control study. Gastroenterol Clin Biol 1996; 20: 544-548